Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Goodwill (2016 - 2025)

Historic Goodwill for Summit Therapeutics (SMMT) over the last 10 years, with Q3 2025 value amounting to $2.0 million.

  • Summit Therapeutics' Goodwill rose 40.18% to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year increase of 40.18%. This contributed to the annual value of $1.9 million for FY2024, which is 153.2% down from last year.
  • According to the latest figures from Q3 2025, Summit Therapeutics' Goodwill is $2.0 million, which was up 40.18% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Summit Therapeutics' Goodwill ranged from a high of $2.1 million in Q2 2021 and a low of $1.7 million during Q3 2022
  • Over the past 5 years, Summit Therapeutics' median Goodwill value was $1.9 million (recorded in 2023), while the average stood at $1.9 million.
  • Its Goodwill has fluctuated over the past 5 years, first soared by 61425.0% in 2021, then tumbled by 1729.14% in 2022.
  • Over the past 5 years, Summit Therapeutics' Goodwill (Quarter) stood at $2.0 million in 2021, then dropped by 10.5% to $1.8 million in 2022, then grew by 5.28% to $1.9 million in 2023, then dropped by 1.53% to $1.9 million in 2024, then increased by 7.24% to $2.0 million in 2025.
  • Its Goodwill was $2.0 million in Q3 2025, compared to $2.0 million in Q2 2025 and $1.9 million in Q1 2025.